5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 49.57▲ | 49.57▲ | 49.57▲ | 49.55▲ | 49.44▲ |
MA10 | 49.56▲ | 49.56▲ | 49.55▲ | 49.47▲ | 49.32▲ |
MA20 | 49.52▲ | 49.51▲ | 49.49▲ | 49.40▲ | 49.61▲ |
MA50 | 49.44▲ | 49.45▲ | 49.42▲ | 49.25▲ | N/A |
MA100 | 49.38▲ | 49.46▲ | N/A | 49.64▼ | N/A |
MA200 | N/A | N/A | N/A | 50.02▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.004▲ | 0.006▲ | 0.026▲ | 0.052▲ |
RSI | 59.551▲ | 59.071▲ | 58.048▲ | 59.085▲ | 48.801▼ |
STOCH | 58.095 | 60.159 | 65.859 | 67.041 | 78.190 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -20.238▲ | -21.170▲ |
CCI | 111.916▲ | 122.581▲ | 119.365▲ | 130.832▲ | 55.747 |
Wednesday, June 04, 2025 02:53 PM
Leerink Partners analysts increased the price target for Genmab A/S (NASDAQ:GMAB) from $29 to $32 and kept an “Outperform” rating. The decision came after Genmab A/S (NASDAQ:GMAB) shared new data on ...
|
Monday, June 02, 2025 09:50 PM
Genmab A/S (NASDAQ:GMAB) has announced promising new data for its investigational antibody-drug conjugate, rinatabart sesutecan (Rina-S), in advanced endometrial cancer. Results from the Phase 1/2 ...
|
Tuesday, May 27, 2025 05:01 AM
In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other biotech stocks. Biotechnology stocks are among the most volatile in the market due to their ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 49.62 | 49.62 | 49.62 | 49.62 | 1,623 |
13/06/25 | 49.67 | 49.69 | 49.49 | 49.50 | 37,300 |
12/06/25 | 49.61 | 49.74 | 49.49 | 49.65 | 7,600 |
11/06/25 | 49.44 | 49.62 | 49.44 | 49.495 | 23,800 |
10/06/25 | 49.49 | 49.49 | 49.46 | 49.47 | 16,441 |
09/06/25 | 49.42 | 49.4696 | 49.2909 | 49.46 | 40,173 |
06/06/25 | 49.37 | 49.41 | 49.31 | 49.372 | 62,500 |
05/06/25 | 49.449 | 49.56 | 49.405 | 49.46 | 58,000 |
04/06/25 | 49.79 | 49.79 | 49.38 | 49.38 | 63,000 |
03/06/25 | 49.37 | 49.73 | 48.95 | 49.25 | 36,600 |
|
|
||||
|
|
||||
|
|